pAAV-CAG-RFP Citations (3)

Originally described in: Preferential labeling of inhibitory and excitatory cortical neurons by endogenous tropism of adeno-associated virus and lentivirus vectors.
Nathanson JL, Yanagawa Y, Obata K, Callaway EM Neuroscience. 2009 Jun 30. 161(2):441-50. PubMed Journal

---

Articles Citing pAAV-CAG-RFP

Articles
Nanoparticles Based on Poly (beta-Amino Ester) and HPV16-Targeting CRISPR/shRNA as Potential Drugs for HPV16-Related Cervical Malignancy. Zhu D, Shen H, Tan S, Hu Z, Wang L, Yu L, Tian X, Ding W, Ren C, Gao C, Cheng J, Deng M, Liu R, Hu J, Xi L, Wu P, Zhang Z, Ma D, Wang H. Mol Ther. 2018 Oct 3;26(10):2443-2455. doi: 10.1016/j.ymthe.2018.07.019. Epub 2018 Jul 25. PubMed
E7-Targeted Nanotherapeutics for Key HPV Afflicted Cervical Lesions by Employing CRISPR/Cas9 and Poly (Beta-Amino Ester). Xiong J, Tan S, Yu L, Shen H, Qu S, Zhang C, Ren C, Zhu D, Wang H. Int J Nanomedicine. 2021 Nov 16;16:7609-7622. doi: 10.2147/IJN.S335277. eCollection 2021. PubMed
Co-Delivery of p53 Restored and E7 Targeted Nucleic Acids by Poly (Beta-Amino Ester) Complex Nanoparticles for the Treatment of HPV Related Cervical Lesions. Xiong J, Li G, Mei X, Ding J, Shen H, Zhu D, Wang H. Front Pharmacol. 2022 Feb 4;13:826771. doi: 10.3389/fphar.2022.826771. eCollection 2022. PubMed

If you have published an article using this material, please email us at to have your article added to this page.